Is Drostanolone Propionate actually useful during a bulking cycle, or is it only for cutting?

Drostanolone Propionate contributes to bulking cycles primarily as a free-androgen amplifier and quality-of-mass agent rather than a primary mass builder. By competitively displacing testosterone from SHBG binding sites, it elevates the bioactive androgen fraction within the existing stack without adding oestrogen load. Experienced athletes use it at 200–400mg per week alongside a testosterone base to sustain androgenic tone and minimise surplus-driven water retention.

What weekly dose of Drostanolone Propionate is typically used during a mass-building phase?

Most practitioners report effective outcomes in bulk-phase protocols at 200–400mg per week, split across every-other-day injections. At 100mg/ml, a 300mg weekly total requires three injections of 1ml each — straightforward arithmetic with no fractional volumes. Starting at the lower end of this range and assessing body composition response over three to four weeks before adjusting is a widely adopted approach for managing androgenic exposure in longer-duration mass cycles.

Which compounds pair most effectively with Drostanolone Propionate in a bulk stack?

Testosterone Enanthate or Testosterone Cypionate forms the anabolic foundation in most bulk stacks incorporating Drostanolone Propionate — the testosterone provides the primary mass-driving stimulus while Drostanolone amplifies free androgen availability and moderates oestrogen-related side effects. Some advanced protocols add Nandrolone Decanoate for additional nitrogen retention. Drostanolone Propionate's non-aromatising nature makes it particularly complementary to aromatising base compounds where oestrogen management is a priority.

What are the storage and handling requirements for the 10x1ml single-dose ampoule format?

Store Sterling Knight Drostanolone Propionate 100mg/ml ampoules at 15–25°C, away from direct light and humidity. Each glass ampoule is hermetically sealed at manufacture and is designed for single-use only — once opened, the entire contents should be drawn and administered without re-sealing. This format eliminates the need for bacteriostatic preservatives and removes multi-puncture contamination risk, which is clinically relevant across a multi-week bulking protocol.

Why is 100mg/ml the most practical concentration for adjusting dose within a bulking stack?

At 100mg/ml, every 0.1ml graduation on a standard 1ml syringe corresponds to exactly 10mg of active Drostanolone Propionate — the finest resolution available in this product category. When integrating this compound into a complex bulking stack where total weekly androgen load is already calculated, that granularity allows 20–50mg weekly adjustments without rounding errors or significant volume changes, making it the most flexible option for athletes fine-tuning their mass-phase protocol week by week. (2) angle_used

Batch Tested

Sterling Knight Pharmaceuticals

Drostanolone 100mg/ml 10x1ml Ampullen by Sterling Knight Pharmaceuticals

Name: Drostanolone 100mg/ml 10x1ml Ampoules by Sterling Knight Pharmaceuticals
Brand: Sterling Knight Pharmaceuticals
SKU: INJ-DROP-STE-100-020
Price: 62.00 EUR
Availability: InStock

Sterling Knight Pharmaceuticals Drostanolone Propionate 100mg/ml is a short-ester injectable androgen formulated across ten individually sealed single-dose glass ampoules, positioned as a muscle-quality anchor within bulking cycles where mass accumulation and lean-tissue preservation must be balanced simultaneously. Unlike typical bulking agents that prioritise sheer anabolic output, Drostanolone Propionate contributes androgenic tone and SHBG displacement to a mass-phase stack — sustaining free androgen availability as caloric surplus and compound load increase. Batch-specific quality is confirmed through reversed-phase HPLC potency verification and LAL endotoxin screening; both results are documented per production lot before distribution.

€62.00Free shipping on orders over €300

In stock

Ships within 48 h Lab-tested batch

Elevates the free-testosterone fraction by competitively occupying SHBG binding sites during high-androgen bulking protocols
Introduces androgenic muscle tone and density that aromatising mass compounds alone do not produce
Non-aromatising structure prevents additional oestrogen load during caloric-surplus phases where water retention is already elevated
Short propionate ester allows dose-response assessment within days, supporting mid-cycle adjustments in extended bulk blocks
100mg/ml concentration delivers the finest dose-titration resolution in the Drostanolone Propionate product range
Single-dose borosilicate ampoules maintain sterility across all ten administrations with no multi-use contamination risk
Batch Tested: every lot cleared through HPLC potency verification and LAL endotoxin assay before distribution

Phase	Dosage	Note
Bulk Foundation (Weeks 1–4)	200mg/week (EOD injections of ~67mg / ~0.67ml)	Establish baseline androgenic tone alongside testosterone base; assess SHBG displacement response before escalating
Bulk Peak (Weeks 5–10)	300–400mg/week (EOD injections of 100–133mg / 1.0–1.33ml)	Increased androgenic overlay during peak caloric surplus; monitor subcutaneous fluid retention and androgenic side effects
Bulk Transition / End of Cycle (Weeks 11–12)	200mg/week (returning to foundation dose)	Tapering androgenic load ahead of cycle exit; propionate ester clears within days, enabling prompt PCT scheduling

Key takeaways

Use Drostanolone Propionate to amplify free androgen availability during a mass-building stack.
Pair with a testosterone base to drive muscle growth while managing oestrogen accumulation.
Dose at 200–400mg per week via every-other-day injections throughout a bulk block.
Confirm lot-specific HPLC and LAL endotoxin results before beginning a long bulking protocol.
Choose 100mg/ml concentration for maximum weekly dose-titration precision within complex stacks.

Drostanolone Propionate in Bulking Cycles: Redefining Its Role Beyond Cutting

Drostanolone Propionate is a 2α-methylated dihydrotestosterone derivative whose androgenic selectivity and SHBG-competitive activity make it a meaningful ancillary compound within structured bulking cycles — not merely a finishing or cutting agent. Most bodybuilders associate this molecule exclusively with pre-contest phases, but a growing body of practitioner experience positions it as a free-androgen amplifier and quality-of-mass modulator during caloric surpluses. Sterling Knight Pharmaceuticals delivers this compound at 100mg/ml across ten single-dose borosilicate ampoules, giving athletes precise control over weekly dose construction throughout a longer bulking block.

How Drostanolone Propionate Contributes to a Mass Phase

Drostanolone Propionate displaces endogenous testosterone from sex hormone-binding globulin, elevating the biologically active free-androgen fraction without requiring a testosterone dose increase — a property that becomes especially valuable when a bulking stack already carries a significant total androgen load. At the same time, its resistance to aromatase activity means it does not contribute to oestrogen-driven water accumulation, which in a caloric surplus is the primary driver of blurred muscularity and excess subcutaneous fluid. Compared to adding a second aromatising compound to a bulk stack, substituting or supplementing with Drostanolone Propionate introduces androgenic stimulus while keeping the oestrogen environment manageable.

Three semantic anchors define its role here: Drostanolone Propionate amplifies free androgen availability by competitively binding SHBG; the 2α-methyl structure resists enzymatic inactivation in skeletal muscle tissue, prolonging receptor occupancy per dose; and the propionate ester enables rapid dose-response verification because serum clearance occurs within days rather than weeks — a logistical advantage for mid-cycle adjustments.

Dose Architecture and the 100mg/ml Concentration Advantage

For bulking applications, experienced practitioners typically run Drostanolone Propionate at 200–400mg per week alongside a testosterone-based foundation, injecting every other day. The 100mg/ml concentration — the entry-level strength in this product category — offers the finest dose-titration resolution: each 0.1ml graduation delivers exactly 10mg, allowing week-to-week adjustments of 20–30mg without reformulating the protocol. A ten-ampoule pack at this concentration supports a five-week EOD block at 400mg per week or a full ten-week run at 200mg weekly, making it a logistically complete single-purchase unit for most bulk-phase applications.

Batch-Tested Quality Supporting Long-Duration Bulk Protocols

Every production lot of Sterling Knight Drostanolone Propionate 100mg/ml is released only after passing two independent analytical checkpoints: reversed-phase HPLC quantification confirming label-stated potency, and LAL endotoxin assay clearing the parenteral safety threshold. Both results are lot-specific and accompany the product at distribution. Single-dose glass ampoules eliminate the multi-access contamination variable inherent in vial formats — a relevant safety consideration when a bulking protocol extends across ten or more weeks of repeated parenteral administration.

Usage

Establish your testosterone-base dose first — Drostanolone Propionate is an ancillary compound in a bulk stack, not the primary mass driver; calculate its weekly dose only after confirming the foundation compound's weekly total.
Select your per-injection dose using the 100mg/ml concentration as a guide: whole-millilitre injections (100mg) or half-millilitre injections (50mg) keep arithmetic clean and volume manageable.
Inject every other day to align with the propionate ester's 2–3 day active half-life, maintaining consistent serum androgen levels throughout the bulking block without significant peak-to-trough fluctuation.
Break each single-dose ampoule at the score line immediately before drawing — never pre-open or store a partially used ampoule, as the format is designed for one-time use only.
Rotate injection sites systematically across the bulking cycle (e.g., alternating glutes and lateral delts) to prevent localised tissue irritation across ten or more weeks of repeated administration.
At mid-cycle (typically weeks 4–5), review body composition markers — muscle fullness, subcutaneous fluid, strength progression — and adjust the weekly Drostanolone Propionate dose by 50–100mg if the androgenic response warrants it, using the lot-verified potency data as your concentration reference.

Warnings

Contraindications: Drostanolone Propionate is contraindicated in individuals with diagnosed prostate or breast carcinoma, pre-existing hepatic impairment, elevated haematocrit above 54%, or known hypersensitivity to androgens or sesame/benzyl-based carrier oils. Women of childbearing age should not use this compound due to virilisation risk. Individuals currently on anticoagulant therapy should seek clinical guidance before initiating any injectable androgen protocol.

Side Effects: Androgenic side effects include accelerated scalp hair loss in genetically predisposed individuals, increased facial and body hair density, and acne — particularly on the upper back and shoulders during caloric-surplus phases where sebum production is already elevated. Adverse lipid shifts (HDL suppression, LDL elevation) are characteristic of all DHT-derivative androgens and are compounded by the high-calorie dietary environment typical of a bulking cycle. Endogenous testosterone suppression occurs at all effective doses and should be anticipated from week one.

Monitoring: Conduct pre-cycle bloodwork including full lipid panel, haematocrit, PSA (males over 30), liver enzymes, and baseline testosterone/LH/FSH values. Repeat lipid and haematocrit panels at mid-cycle — approximately weeks 5–6 in a 10-week bulk block — given that dietary caloric surplus additively stresses the cardiovascular lipid profile. Blood pressure should be monitored monthly, as androgen-driven haematocrit increases combined with high-calorie intake can elevate systolic pressure meaningfully.

PCT: Because the propionate ester clears within approximately 3–5 days of the final injection, post-cycle therapy can begin promptly — typically within 5–7 days. Standard PCT protocols involving a SERM (tamoxifen or clomiphene) are recommended for a minimum of four weeks to restore endogenous hypothalamic-pituitary-gonadal axis function following suppression incurred during the bulking cycle. Full hormonal recovery should be confirmed via repeat LH, FSH, and total testosterone bloodwork at weeks 4 and 8 of PCT.

Frequently asked questions

Is Drostanolone Propionate actually useful during a bulking cycle, or is it only for cutting?: Drostanolone Propionate contributes to bulking cycles primarily as a free-androgen amplifier and quality-of-mass agent rather than a primary mass builder. By competitively displacing testosterone from SHBG binding sites, it elevates the bioactive androgen fraction within the existing stack without adding oestrogen load. Experienced athletes use it at 200–400mg per week alongside a testosterone base to sustain androgenic tone and minimise surplus-driven water retention.
What weekly dose of Drostanolone Propionate is typically used during a mass-building phase?: Most practitioners report effective outcomes in bulk-phase protocols at 200–400mg per week, split across every-other-day injections. At 100mg/ml, a 300mg weekly total requires three injections of 1ml each — straightforward arithmetic with no fractional volumes. Starting at the lower end of this range and assessing body composition response over three to four weeks before adjusting is a widely adopted approach for managing androgenic exposure in longer-duration mass cycles.
Which compounds pair most effectively with Drostanolone Propionate in a bulk stack?: Testosterone Enanthate or Testosterone Cypionate forms the anabolic foundation in most bulk stacks incorporating Drostanolone Propionate — the testosterone provides the primary mass-driving stimulus while Drostanolone amplifies free androgen availability and moderates oestrogen-related side effects. Some advanced protocols add Nandrolone Decanoate for additional nitrogen retention. Drostanolone Propionate's non-aromatising nature makes it particularly complementary to aromatising base compounds where oestrogen management is a priority.
What are the storage and handling requirements for the 10x1ml single-dose ampoule format?: Store Sterling Knight Drostanolone Propionate 100mg/ml ampoules at 15–25°C, away from direct light and humidity. Each glass ampoule is hermetically sealed at manufacture and is designed for single-use only — once opened, the entire contents should be drawn and administered without re-sealing. This format eliminates the need for bacteriostatic preservatives and removes multi-puncture contamination risk, which is clinically relevant across a multi-week bulking protocol.
Why is 100mg/ml the most practical concentration for adjusting dose within a bulking stack?: At 100mg/ml, every 0.1ml graduation on a standard 1ml syringe corresponds to exactly 10mg of active Drostanolone Propionate — the finest resolution available in this product category. When integrating this compound into a complex bulking stack where total weekly androgen load is already calculated, that granularity allows 20–50mg weekly adjustments without rounding errors or significant volume changes, making it the most flexible option for athletes fine-tuning their mass-phase protocol week by week. (2) angle_used

Manufacturer

Sterling Knight Pharmaceuticals' approach to analytical quality for its Drostanolone Propionate 100mg/ml product is built around a two-checkpoint batch-release model: no lot proceeds to distribution until reversed-phase HPLC has confirmed active compound concentration against the 100mg/ml label claim, and a separate LAL endotoxin assay has verified that endotoxin load falls within pharmacopoeial parenteral safety limits. Critically, these are not periodic audits — they are mandatory pre-release requirements applied to every individual production batch. The corresponding data is lot-specific: each Certificate of Analysis is generated against the batch number accompanying the shipped product, giving athletes and practitioners a traceable reference point rather than a generic quality statement. This batch-specific accountability model is the foundation of the brand's Batch Tested positioning, and it is operationalised under a GMP-certified manufacturing environment that covers aseptic fill conditions, raw API sourcing traceability, and finished-product container integrity across the single-dose ampoule format.

Product details

Brand	Sterling Knight Pharmaceuticals
Active ingredient	drostanolone propionate
Also known as	Masteron, Drolban, Drostanolone Propionate, Drostanolonee, Sterling Knight Pharmaceuticals Masteron
Strength	100 mg
Form	Ampullen
Pack size	10 pieces
Item number	INJ-DROP-STE-100-020

Reviews

No reviews yet. Be the first to review this product.

Write a review

Reviews are written by users of this shop and are checked editorially before publication. Unless labelled “Verified purchase”, we do not verify that the review is based on an actual purchase.

Similar products

Optimal Dosage

Propha-Masteron 100mg/ml 10ml Vial by Beligas Pharmaceuticals

Propha-Masteron is an oil-based injectable solution delivering Drostanolone Propionate at 100mg/ml, distinguished by its capacity to bypass hepatic first-pass metabolism entirely — a pharmacokinetic advantage that oral androgen compounds cannot replicate. Each 10ml multi-dose vial provides a full cycle's supply of pharmaceutical-grade active, with systemic absorption occurring directly through intramuscular tissue into the bloodstream. Quality assurance is built into every lot: HPLC potency verification, LAL endotoxin screening, and GMP-certified filling suites are standard — not optional — at Beligas Pharmaceuticals.

€46.00

Masten-100 100mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Fast Acting

Masten-100 100mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Masten-100 is a fast-acting injectable androgenic compound delivering Drostanolone Propionate at 100mg/ml in single-dose 1ml ampoules, specifically engineered for rapid tissue uptake and measurable efficacy within the first days of administration. The propionate ester's short carbon chain enables peak plasma concentrations to establish quickly — typically within 24–48 hours of the first injection — making it one of the fastest-onset drostanolone formulations available. Every lot is released only after HPLC potency confirmation and LAL endotoxin screening; sterility is assured via Ph. Eur. 2.6.1-compliant testing conducted at BM Pharmaceuticals' GMP-certified facility.

€47.00

High Concentration

MasterTrex 150mg/ml 10ml Vial by Concentrex Labs

MasterTrex is a high-concentration Drostanolone Propionate injectable, formulated at 150 mg/ml in a 10 ml multi-dose vial and engineered for athletes who demand precise, schedule-driven injection timing across their cutting or pre-contest phase. At 150 mg/ml, each draw delivers a clinically meaningful dose in a compact volume, making every-other-day or every-third-day scheduling straightforward without excess injection site load. Quality is locked in at batch level: HPLC-quantified potency verification and LAL endotoxin testing are completed before any MasterTrex vial leaves the Concentrex Labs facility.

€50.00

Brand Quality

Masteron 100 100mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma Masteron 100 is a drostanolone propionate injectable solution at 100mg/ml in a 10ml multi-dose vial, specifically suited to frontloading protocols that compress the time-to-steady-state window at the opening of a cycle. Because the propionate ester releases active drostanolone within a short half-life of approximately 2–3 days, calculated loading doses can bring circulating androgen levels to the target therapeutic range within the first 72 hours rather than waiting the usual week or more. Dragon-Pharma batch-releases every vial only after HPLC potency verification and LAL endotoxin clearance — two independent quality gates applied sequentially before product leaves the facility.

€42.00

Stack it with

Pairs well with these products.

High Concentration

Quant-Equipoise 300mg/ml 10ml Vial by Beligas Pharmaceuticals

Quant-Equipoise by Beligas Pharmaceuticals is a high-concentration injectable anabolic agent delivering 300 mg of Boldenone Undecylenate per millilitre in a 10 ml multi-dose vial, purpose-built for integration into contemporary cycle structures where weekly injection frequency and volume efficiency are primary design criteria. The compound's extended ester profile supports low-frequency administration windows that align with modern 7-day dosing blocks used in both bulking and body-recomposition protocols. Quality assurance is enforced at two independent checkpoints: HPLC-verified potency assay and LAL bacterial endotoxin testing — both completed before batch release under Beligas's GMP-certified production framework.

€47.00

Bolden-250 250mg/ml 10x1ml Ampoules by BM Pharmaceuticals

Long-Acting Formula

Bolden-250 250mg/ml 10x1ml Ampullen by BM Pharmaceuticals

Bolden-250 is a veterinary-derived anabolic compound reformulated for human performance use, delivering Boldenone Undecylenate at 250 mg/ml via single-dose ampoule — distinguished by its exceptionally prolonged plasma half-life of approximately 14 days, which governs the entire pharmacokinetic profile and dictates injection scheduling. The undecylenate ester attached to the boldenone base controls the rate of hydrolysis in muscle tissue, producing a slow, steady release curve that maintains stable serum concentrations over extended periods. Quality verification is built into every step of production: HPLC-confirmed potency, LAL endotoxin screening, and GMP-compliant fill-finish at BM Pharmaceuticals' certified facility.

€48.00

Brand Quality

EquiTrex 350mg/ml 10ml Vial by Concentrex Labs

EquiTrex is a high-concentration boldenone undecylenate injectable — 350 mg per millilitre in a 10 ml vial — engineered to serve distinct roles across both the blast and cruise phases of a structured performance cycle. Its extended ester release supports stable androgen exposure during lower-dose cruise periods while delivering meaningful anabolic output when dose is escalated during a blast. Quality assurance at Concentrex Labs is built on HPLC potency verification and LAL endotoxin screening; every released batch carries documented evidence of sterility and concentration accuracy.

€52.00

Pro Choice

EQ 300 300mg/ml 10ml Vial by Dragon-Pharma

Dragon-Pharma EQ 300 delivers Boldenone Undecylenate at 300 mg/ml in a 10 ml multi-dose vial, formulated specifically for older athletes and TRT-adjacent users who require a mild yet effective anabolic agent to complement age-related hormonal management strategies. Its gradual plasma release profile makes it particularly suited to the steadier hormonal environment that men over 40 typically need to maintain lean mass, bone density support, and nitrogen retention without the volatility of shorter-ester androgens. Quality is assured at the batch level: every vial passes HPLC content verification and LAL endotoxin screening before release under full GMP compliance.

€44.00